Literature DB >> 23657649

Expression of acetylcholine receptors in the brain of mice at the presymptomatic stage of Parkinson's disease.

E V Kryukova1, I V Shelukhina, E A Kozina, M V Ugryumov, V I Tsetlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23657649     DOI： 10.1134/S1607672913020038

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  15 in total

1.  Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Authors:  Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.

Authors:  Hiroki Takeuchi; Takashi Yanagida; Masatoshi Inden; Kazuyuki Takata; Yoshihisa Kitamura; Kentaro Yamakawa; Hideyuki Sawada; Yasuhiko Izumi; Noriyuki Yamamoto; Takeshi Kihara; Kengo Uemura; Haruhisa Inoue; Takashi Taniguchi; Akinori Akaike; Ryosuke Takahashi; Shun Shimohama
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

3.  The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

Authors:  C D Marsden
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

Review 4.  Assembly of nicotinic and other Cys-loop receptors.

Authors:  Victor Tsetlin; Dmitry Kuzmin; Igor Kasheverov
Journal:  J Neurochem       Date:  2011-01-13       Impact factor: 5.372

5.  Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.

Authors:  M V Ugrumov; V G Khaindrava; E A Kozina; V G Kucheryanu; E V Bocharov; G N Kryzhanovsky; V S Kudrin; V B Narkevich; P M Klodt; K S Rayevsky; T S Pronina
Journal:  Neuroscience       Date:  2011-03-05       Impact factor: 3.590

Review 6.  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.

Authors:  Michael W Jakowec; Giselle M Petzinger
Journal:  Comp Med       Date:  2004-10       Impact factor: 0.982

Review 7.  Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism.

Authors:  M J Zigmond
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

8.  Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.

Authors:  Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis J David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco M Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

9.  Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone.

Authors:  Pheona M Radcliffe; Carol R Sterling; A William Tank
Journal:  J Neurochem       Date:  2009-03-23       Impact factor: 5.372

10.  Smoking and Parkinson's disease: a dose-response relationship.

Authors:  J M Gorell; B A Rybicki; C C Johnson; E L Peterson
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.